Log inStart free trialBook a demo
Log inStart free trial
Media Database
>
Rose McNulty

Rose McNulty

Associate Editorial Director at The American Journal of Managed Care

Contact this person
Email address
r*****@*******.comGet email address
Influence score
34
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Biology/Microbiology
  • General Assignment News
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

ajmc.com

FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome

FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome
about 1 month ago
ajmc.com

Striking a Balance: Innovation, Affordability, and Equitable Access...

Striking a Balance: Innovation, Affordability, and Equitable Access in Cancer Care
about 1 month ago
ajmc.com

Bridging the Gap Between Cutting-Edge Cancer Care and Equitable Access

Bridging the Gap Between Cutting-Edge Cancer Care and Equitable Access
about 1 month ago
ajmc.com

Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices

Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
about 2 months ago
ajmc.com

CMS Announces GENEROUS Model to Lower Medicaid Drug Prices

CMS Announces GENEROUS Model to Lower Medicaid Drug Prices
about 2 months ago
ajmc.com

Chronic Spontaneous Urticaria Linked to Increased Heart Disease Risk

Chronic Spontaneous Urticaria Linked to Increased Heart Disease Risk
about 2 months ago
ajmc.com

Delivering Value-Based Oncology Care in the Age of Biomarker Testin...

Delivering Value-Based Oncology Care in the Age of Biomarker Testing, Targeted Therapies, and Immunotherapies
about 2 months ago
ajmc.com

Mepolizumab Reduces Health Care Resource Utilization, Work Impairme...

Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma
about 2 months ago
ajmc.com

FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory ...

FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2 months ago
ajmc.com

A "One-Two Punch" to Innovation? The Most Favored Nation Order and ...

A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform
2 months ago
ajmc.com

AI–Enhanced SALT Score Improves Accuracy in Alopecia Areata Assessment

AI–Enhanced SALT Score Improves Accuracy in Alopecia Areata Assessment
2 months ago